GLMD icon

Galmed Pharmaceuticals
GLMD

Overview Fund Activity

19 hedge funds and large institutions have $10M invested in Galmed Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
19
Holders Change
-1
Holders Change %
-5%
% of All Funds
0.55%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
7
Increased
3
Reduced
4
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Wells Fargo
Wells Fargo
California
$1.02M
2
Goldman Sachs
Goldman Sachs
New York
$117K
3
EMG
Ellington Management Group
Connecticut
$96K
4
Morgan Stanley
Morgan Stanley
New York
$120K
5
Geode Capital Management
Geode Capital Management
Massachusetts
$170K

Top Sellers

1
SFM
Sphera Funds Management
Israel
$0
2
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
$0
3
PRCM
Pine River Capital Management
Minnesota
$680K
4
GPCM
Granite Point Capital Management
Massachusetts
$0
5
DCM
DAFNA Capital Management
California
$1.01M
Name Holding Trade Value Shares
Change 		Shares
Change %
Deutsche Bank
26
Deutsche Bank
Germany
– -$194K -111 Closed
TRCT
27
Tower Research Capital (TRC)
New York
– -$19K -11 Closed
Royal Bank of Canada
28
Royal Bank of Canada
Ontario, Canada
– -$1K – –
1
2